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renewed efforts to eliminate malaria. The presentation
includes suggestions for lessons learnt from the eradication
era to be borne in mind.22 14
8.004
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Heightened global concern about an inﬂuenza pandemic
an be dated back to 2003, when the SARS outbreak was
ollowed by the spread of highly pathogenic A (H5N1) infec-
ions in poultry with occasional spread to humans. These
llnesses had a high case fatality ratio, which increased the
orry of the potential effect of a pandemic caused by this
ubtype. The WHO developed a variety of tools for countries
o use and made preparations for vaccine stockpiling. Plans
ere developed to contain any focal outbreak with antivi-
als. Pandemic phases were established to deﬁne extent
f adaption of an animal virus to humans and subsequent
pread. Severity of the pandemic was not quantiﬁed in a
cale. Fortuitously, modiﬁcation of the phases had been put
n place well before transmission of pandemic H1N1 virus
as recognized in April, 2009.
The H1N1 pandemic has been very different from that
nticipated based on the virulence of the H5N1 virus. Para-
oxically, this was initially a problem, since some countries’
lans were geared only to severe pandemics. Some bor-
ers were effectively closed for a time, even though this
as against the pandemic IHR recommendation. There was
lso confusion between containment and mitigation, in
art because of the rapidity of spread of the virus. Over-
ll, preparations for a more severe pandemic had positive
esults. Many developed countries had antiviral stockpiles,
hich they used in different ways. Development of a mono-
alent pandemic vaccine moved ahead rapidly. Not only
ere adjuvanted and nonadjuvanted inactivated vaccines
sed but live attenuated vaccines were employed as well.
echnology transfer will make these approaches available in
ore countries. The need for only one inoculation of vac-
ine will make more vaccine available to risk or priority
roups in developing countries. Equity issues clearly need to
e addressed as we go forward. The time periods between
andemics have been irregular, and the next might not wait
0 years to occur.
oi:10.1016/j.ijid.2010.02.1534
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Malaria transmission was eliminated from a number of
erritories in the Americas but still occurs in 21 countries
n the Region. The presentation focuses on past and present
trategies and goals to combat malaria in the Region, trends,
he present situation and challenges as well as on ﬁnan-
ial resource mobilization including that for operational
esearch. After the Global Malaria Eradication Strategy was
bandoned, it was replaced by the Global Malaria Control
dternational Congress on Infectious Diseases (ICID) Abstracts
trategy in 1992 and the strengthening of efforts to reduce
he global burden of the disease was catalyzed by the Roll
ack Malaria Initiative (RBM) which was launched in 1998.
he goal of the RBM initiative was to reduce the burden
f disease by 50% by 2010. The United Nations Millennium
evelopment Goals were launched in 2000 with Goal 6 call-
ng ‘‘to halt and begin to reverse the incidence of malaria
y 2015’’. At the World Health Assembly in 2005, Resolution
HA58.2 called for an additional 25% reduction from the
BM target; with the goal of reducing the burden between
000 and 2015 by 75%. The burden of malaria reported in the
mericas by Member States decreased from over one million
ases and over three hundred deaths in 2000 to just under
73 thousand cases representing a 52% reduction in cases
nd 57% reduction in malaria related deaths between 2000
nd 2008.
Plasmodium vivax is the leading cause of malaria in the
egion, accounting for approximately 75% of all cases with
. falciparum being the cause of almost all other cases and
small number due to P. malariae. In the countries shar-
ng the Amazon rain forest, similar proportions are observed
hile in Mexico, Central America, Argentina and Paraguay P.
ivax accounts for over 90% of the cases. In Hispaniola, the
nly endemic island in the Caribbean shared by the Domini-
an Republic and Haiti; almost 100% of the cases are due
o P. falciparum. There has been a reduction in the over-
ll malaria incidence in recent years but the disease still
onstitutes a public health problem in the region with a dis-
arity in outcome of efforts in different countries related to
number of factors including variations in ecological con-
itions, diagnostic and treatment coverage, weaknesses in
ealth systems and technical capacity issues. Operational
esearch is important for evidenced based decision making.
The greater part of the ﬁnancial resources for national
alaria efforts to combat the disease is provided by national
overnments but there has also been additional resource
obilization in the Region including that of the Amazon
etwork for Monitoring Antimalarial Drug Resistance with
unding available through the United States Agency for Inter-
ational Development’s (USAID) Amazon Malaria Initiative
AMI). Additionally, individual country projects in Bolivia,
uatemala, Guyana, Haiti, Honduras, Nicaragua and Suri-
ame have been ﬁnanced by the Global Fund to combat
IV/AIDS, Tuberculosis and Malaria (GFATM) as has been a
ulti-country Andean proposal by the Organismo Andino
e Salud (ORAS) to the GFATM for Colombia, Ecuador, Peru
nd Venezuela. Towards the end of 2009, proposals by
razil, Colombia, the Dominican Republic and Ecuador were
pproved by the GFATM. The Global Environment Facility /
N Environmental Program also supported a project for the
revention of the reintroduction of DDT use inmalaria vector
ontrol in Mexico and Central America.
With reduction of the malaria burden in different geo-
raphical regions worldwide, there have been calls foroi:10.1016/j.ijid.2010.02.1535
